| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.3M | -91.9% |
| Cost of Revenue | $0 | -100.0% |
| R&D Expense | $18.1M | -62.8% |
| SG&A Expense | $14.6M | -20.8% |
| Operating Income | -$39.6M | -0.8% |
| Pre-tax Income | -$38.8M | +28.9% |
| Income Tax | $11K | — |
| Net Income | -$38.8M | +28.9% |
| EPS (Basic) | -$1.29 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $50.5M | -43.1% |
| Current Assets | $51.4M | -43.6% |
| Total Assets | $52.8M | -45.3% |
| Current Liabilities | $6.4M | -43.6% |
| Total Liabilities | $9.0M | -39.9% |
| Stockholders' Equity | $43.8M | -46.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$38.4M | +27.1% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | -$60K | -100.1% |
| Free Cash Flow | -$38.4M | +27.6% |
| +33.2% |
| EPS (Diluted) | -$1.29 | +33.2% |